China Hemodialysis Industry Report, 2009-2010
  • Nov/2010
  • Hard Copy
  • USD $1,500
  • Pages:54
  • Single User License
    (PDF Unprintable)       
  • USD $1,600
  • Code: JMH001
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,400
  • Hard Copy + Single User License
  • USD $1,700
In 2009, China’s hemodialysis equipment market scale reached RMB1.06 billion, representing less than 2% of the world’s total. There are only 10-15% patients suffering end-stage renal failure accepting dialysis therapy, lagging far behind the 95% in developed countries and indicating considerable market potential.  

Chinese hemodialysis equipment manufacturers as latecomers feature underdeveloped technology and poor competitiveness, resulting in the low market occupancy. At present, China imports over 90% of the hemodialysis equipment such as dialysis machines, dialysers and blood tubing sets from Europe and Japan. Take hemodialyzer for example, four foreign enterprises - Germany-based Fresenius, Japan-based Nipro and Asahi, Sweden-based Gambro - held a lion’s share of 69% in Chinese market in 2009, while the largest domestic enterprise - Shandong Weigao - only occupied 4.5%.

Market Share of Hemodialyzer Manufacturers in China by Sales Value, 2009
Source: ResearchInChina

This report not only highlights the status quo, competition pattern and development trend of the hemodialysis industry and market segments, but elaborates on the operation and prospect of five foreign hemodialysis equipment manufacturers including Germany-based Fresenius, Japan-based Nikkiso and Asahi, America-based Baxter International and Sweden-based Gambro as well as several large-scale domestic hemodialysis equipment manufacturers.

An overwhelming majority of Chinese enterprises focus on making products with low technological content such as blood tubing set and dislysate, while few enterprises are engaged in the production of high-end dialyzers and dialysis machines.

Shandong Weigao is a leading domestic enterprise in China’s dialyzer market. In April 2010, Weigao collaborated with Nikkiso to develop and sell dialysis machines. Guangzhou Jihua Medical Apparatus and Instruments, the only domestic manufacturer specializing in the mass production of hemodialysis machines, ranked the first place in terms of export value during January-August, 2010.

Bain Medical Equipment (Guangzhou) is a professional supplier of hemodialysis consumables, and also the largest blood tubing set supplier in China. In August 2008, Bain began to provide OEM service for Asahi Kasei Kuraray Medical, making itself one of the few enterprises providing OEM service for mid-and high-end products of world-renowned medical device enterprises.

Beijing United Jie Ran Bio-Tech is a domestic manufacturer specializing in the production of hemodialysis water and dialysis powder, and is the general agent of Germany-based B. Braun Group’s hemodialysis products in North China. Jiangsu Lengthen Life Science and Technology is a competitive enterprise specializing in the production of hollow-fiber hemodialyzers, with an annual capacity of 3.4 million dialyzers.
1. Overview of Hemodialysis Industry
1.1 Definition and Classification
1.2 Industry Chain

2. Chinese Hemodialysis Market
2.1 Global Development 
2.2 Domestic Development
2.3 Policy Environment 
2.4 Competition Pattern 
2.5 Market Supply and Demand
2.6 Market Prospect
2.6.1 Increased Population Accepting Hemodialysis Therapy 
2.6.2 Stable Improvement in Dialysis Treatment Rate

3. China’s Import and Export of Hemodialysis Equipment in 2010
3.1 Import
3.2 Export

4. Hemodialysis Industry Segments
4.1 Dialyser
4.2 Dialysis Machine
4.3 Blood Tubing Set
4.4 Dialysis Concentrate
4.5 Peritoneal Dialysis Equipment
4.6 Hemodialysis Machine for Family Use

5.Foreign Manufacturers
5.1 Fresenius Medical Care
5.1.1 Profile
5.1.2 Overall Operation
5.1.3 Operation of Hemodialysis Business
5.1.4 Development Trend
5.1.5 Operation in China
5.2 Nikkiso
5.2.1 Profile
5.2.2 Operation of Hemodialysis Business
5.2.3 Operation in China
5.3 Baxter International
5.3.1 Profile
5.3.2 Operation of Hemodialysis Business
5.3.3 Operation in China
5.4 Gambro
5.4.1 Profile
5.4.2 Operation
5.4.3 Development Trend
5.4.4 Operation in China
5.5 Asahi Kasei Corporation
5.5.1 Profile
5.5.2 Operation
5.5.3 Operation of Hemodialysis Business
5.5.4 Development Trend
5.5.5 Operation in China

6. Domestic Manufacturers
6.1 Weigao
6.1.1 Profile
6.1.2 Overall Operation
6.1.3 Operation of Hemodialysis Business
6.2 Guangzhou Ji Hua Medical Apparatus and Instruments
6.2.1 Profile
6.2.2 Operation
6.2.3 Development Trend
6.3 Bain Medical Equipment (Guangzhou)
6.3.1 Profile
6.3.2 Operation
6.3.3 Development Trend
6.4 Beijing United Jie Ran Bio-Tech
6.4.1 Profile
6.4.2 Operation of Hemodialysis Business
6.5 Jiangsu Lengthen Life Science and Technology
6.5.1 Profile
6.5.2 Operation of Hemodialysis Business
6.5.3 Development Trend
Hemodialysis Industry Chain
Population suffering from End-stage Renal Disease and Population Accepting hemodialysis Therapy, 2001-2009
Distribution of Population Accepting Hemodialysis Therapy and Growth Rate by Region, 2008
Trade Deficit of Hemodialysis Machine in January-September, 2008-2010 
Market Shares of Domestic Manufacturers and Foreign Manufacturers in Hemodialysis Market by Sales Value, 2009
Distribution of Hemodialysis Equipment Manufacturers by Region
Market Scale of Hemodialysis Industry of China, 2009
Positive Correlation between ESRD Patients/1 million People and Per Capita GDP
Import Value of Hemodialysis Machine, 2005-2010
Import Volume of Hemodialysis Machine in China, 2008-2010 
Proportion of Hemodialysis Machine Imported from Different Countries by Import Value, January-August 2010
Top 10 Hemodialysis Equipment Importers by Value, January-August 2010
Hemodialysis Equipment Importers by Region, January-August 2010
Export Value of Hemodialysis Machine, 2005-2010 
Hemodialysis Equipment Exporters by Region, January-August 2010
Proportion of Hemodialysis Machine Export Destinations by Export Value, January-August 2010
Prices of Common Home-made and Import Dialysers, 2009 
Market Occupancy of Hemodialyzer Manufacturers in China by Sales Value, 2009
Import & Export Value of Hemodialysis Machine in China, 2005-2010
Comparison of Import & Export Prices of Hemodialysis Machine in China, 2008-2010 
Latest Small-Sized Hemodialysis Machines
Five Branches of Fresenius Group 
Gross Operating Income and Total Profit of Fresenius Medical Care Worldwide, 2006-2010 
Hemodialysis Service Revenue and Growth Rate of Fresenius Medical Care Worldwide, 2008-2010 
Hemodialysis Product Revenue and Growth Rate of Fresenius Medical Care Worldwide, 2008-2010 
Operating Income and Proportion of Industrial Sector and Medical Sector under Nikkiso, FY2008-FY2009 
Operating Income and Total Profit of Nikkiso, 2005-2009
Operating Income and Total Profit of Nikkiso in Asia, 2006-2010
Three Business Sectors of Baxter International Worldwide
Operating Income and Total Profit of Baxter International, 2006-2010
Proportion of Peritoneal Dialysis Business
Proportion of Peritoneal Dialysis Business Revenue to Total Revenue of Baxter International, 2007-2009 
Net Sales and Net Profit of Gambro, 2007-2009
Nine Operating Companies and Main Businesses of Asahi
Operating Income and Net profit of Asahi, 2005-2009
Operating Income from Medical Sector and Industrial Sector of Nikkiso, FY2008-FY2009 
Operating Income and Profit from Health Care Sector of Asahi, FY2008-FY2009 
Operating Income and Profit of Asahi Kasei Medical (Hangzhou), 2007-2008 
Gross Operating Income and Total Profit of Weigao, 2006-2010 
Operating Income and Growth Rate of Hemodialysis Business of Weigao, 2006-2010 
Revenue and Proportion of Hemodialysis Business of Weigao, 2006-2010
Operating Income and Total Profit of Beijing United Jie Ran Bio-Tech, 2007-2008

China Interventional Cardiovascular Device Industry Report,2014-2017

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing ye...

China PTCA Balloon Market Investment Report, 2014-2016

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. There...

China Orthopedic Instrument Industry Report, 2014-2017

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale ...

China Hospital Development and Investment Report, 2014-2017

China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6...

China Diagnostic Reagent Industry Report, 2013-2016

With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic re...

China Hemodialysis Equipment Import and Export Report, 2013-2016

Hemodialysis equipment is the most widely used treatment apparatus in blood purification, primarily targeting patients with acute or chronic renal failure.The Chinese hemodialysis equipment market sho...

Global and China Hemodialysis Industry Report, 2013-2016

Hemodialysis, also known as artificial kidney, is a type of blood purification technology, primarily applicable to the treatment of patients with rental failure. In 2013, the global number of patient...

China Portable Medical Equipment Industry Report, 2013-2016

With the synergy of favorable policies, improvement in living standards and healthcare awareness raising, China’s portable medical device industry has shown rapid development in recent years, with mar...

China Medical Informatization Industry Report,2013-2016

Under the impetus of multiple favorable policies and market demand, China's medical informatization industry has entered a rapid development stage in recent years. As of the first half of 2013, manage...

China Aged Care Industry Report, 2013-2016

Currently, China has entered the accelerated aging period. China’s population aged 65 and above reached 131.61 million in 2013, accounting for 9.7% of total population; and the proportion will rise to...

China Pharmaceutical Equipment Industry Report, 2013-2016

After decades of development, China has become a major producer of pharmaceutical equipment in the world. Since 2010, affected by the new GMP certification and other factors, the revenue and total pro...

China Dental Industry Report, 2013-2016

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental appliances (equipments and consumables), dental medical services, etc. with...

China Medical Monitor Industry Report, 2013-2015

In 2007-2011, the Chinese medical monitor market size rose from RMB1.16 billion to RMB3.08 billion at a CAGR of 27.8%. In 2012, the figure reached RMB3.86 billion, a year-on-year increase of 25.3%, of...

China Interventional Cardiovascular Device Industry Report, 2013-2015

With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People’s Republi...

China Diagnostic Reagent Industry Report, 2013-2015

Driven by huge population base, intensified aging and many favorable policies, China diagnostic reagent industry has been developing rapidly. In 2008-2012, the diagnostic reagent market size presented...

China Orthopedic Instrument Industry Report, 2013-2015

Benefiting from aging of population, consumption upgrade and policy support, China's orthopedic instrument industry has seen rapid development over the years, with total market size rising from 3.28 b...

China Ophthalmic Hospital Industry Report, 2012-2015

With the growing types of eye diseases and non-basic medical needs, China’s ophthalmic hospital industry has seen rapid development. In 2011, the number of ophthalmic hospitals in China reached 288, w...

China Chinese Patent Medicine Industry Report, 2012-2015

In recent years, China’s Chinese patent medicine industry has been running in good condition, with the revenue increasing from RMB 142 billion in 2008 to RMB 360 billion in 2012 at a CAGR of 26.2%. Ov...

2005-2014 All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号